Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Nicotine via Research ENDS S-TA-U001 in Smokers and Vapers
NCT02792426Phase 1Completed
- Sponsor
- NJOY
- Start
- Oct 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nicotine in nicotine dependence (3 arms), sponsored by NJOY. Primary endpoints: Maximum Plasma Concentration of Nicotine at Day 5, Area Under the Concentration-Time Curve of Nicotine at Day 5 and 2 more. Started Oct 2016; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02792426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02792426.